Blanca Fuentes Selected Research

Solutions

1/2019

Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Blanca Fuentes Research Topics

Disease

49	Stroke (Strokes) 01/2022 - 01/2007
25	Ischemic Stroke 01/2022 - 01/2009
7	Infarction (Infarctions) 01/2022 - 02/2009
6	Hypertension (High Blood Pressure) 01/2020 - 01/2009
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 07/2011
4	Embolic Stroke 01/2020 - 08/2014
4	Cerebral Infarction 11/2018 - 03/2010
3	Infections 05/2022 - 01/2013
3	COVID-19 05/2022 - 01/2021
3	Aphasia (Dysphasia) 01/2022 - 11/2018
3	Thrombosis (Thrombus) 01/2022 - 01/2009
3	Hyperglycemia 11/2020 - 10/2010
3	Ischemia 01/2020 - 08/2014
3	Hemorrhage 09/2018 - 07/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2015 - 02/2012
2	Inflammation (Inflammations) 07/2021 - 01/2009
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020 - 01/2015
2	Brain Ischemia (Cerebral Ischemia) 08/2014 - 01/2009
2	Transient Ischemic Attack 04/2012 - 01/2009
2	Cerebral Hemorrhage 01/2012 - 07/2011
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Atherosclerosis 07/2021
1	Wernicke Aphasia (Receptive Aphasia) 01/2021
1	Critical Illness (Critically Ill) 11/2020
1	Broca Aphasia (Expressive Aphasia) 01/2019
1	Paraproteinemias (Monoclonal Gammopathy) 11/2018
1	Multiple Myeloma 11/2018
1	POEMS Syndrome (Syndrome, POEMS) 11/2018
1	Myocardial Infarction 01/2018
1	Diabetes Mellitus 01/2018
1	Leukoaraiosis 01/2018
1	Siderosis 01/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2016
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016
1	Vascular Malformations 01/2016
1	Diplopia (Double Vision) 05/2015
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 05/2015
1	Ataxia (Dyssynergia) 05/2015
1	Neoplasms (Cancer) 02/2015
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2015
1	Hypercholesterolemia 09/2014
1	Brain Infarction 08/2014

Drug/Important Bio-Agent (IBA)

9	AnticoagulantsIBA 01/2020 - 07/2011
6	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 02/2009
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2014
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2009
3	Insulin (Novolin)FDA Link 11/2020 - 10/2010
3	SynaptophysinIBA 01/2019 - 02/2012
3	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2012 - 09/2008
2	salicylhydroxamic acid (SHAM)IBA 11/2020 - 05/2015
2	Streptozocin (Streptozotocin)FDA Link 11/2020 - 01/2019
2	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2020 - 01/2019
2	Glial Fibrillary Acidic ProteinIBA 01/2019 - 02/2015
2	A-factor (Streptomyces)IBA 07/2016 - 08/2011
2	Endothelin-1 (Endothelin 1)IBA 06/2015 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015 - 02/2012
2	Antihypertensive Agents (Antihypertensives)IBA 09/2014 - 03/2010
1	fibrin fragment D (D-dimer)IBA 05/2022
1	COVID-19 VaccinesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 07/2021
1	EnzymesIBA 07/2021
1	ImmunosorbentsIBA 07/2021
1	MicroRNAs (MicroRNA)IBA 07/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	CollagenIBA 01/2019
1	SolutionsIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2018
1	Lenalidomide (CC 5013)FDA Link 11/2018
1	Vitamin K FDA Link 09/2018
1	Blood Glucose (Blood Sugar)IBA 03/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	fedratinibIBA 05/2015
1	Type 1 Angiotensin ReceptorIBA 05/2015
1	olmesartanIBA 05/2015
1	Janus Kinase 2IBA 05/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015
1	Antiphospholipid AntibodiesIBA 01/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2015
1	2',3'-Cyclic Nucleotide 3'-PhosphodiesteraseIBA 01/2015
1	Immunoglobulin M (IgM)IBA 01/2015
1	Myelin Basic ProteinIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 01/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2014

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2007
6	Thrombectomy 01/2021 - 05/2016
4	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 10/2012
3	Intravenous Administration 01/2021 - 01/2013
2	Language Therapy (Language Training) 01/2022 - 01/2021
1	Punctures 01/2021
1	Intraperitoneal Injections 11/2020
1	Aftercare (After-Treatment) 09/2018
1	Glycemic Control 01/2018
1	Secondary Prevention 01/2016
1	Patient Transfer (Patient Dumping) 08/2015